Delisting riskPopularity #4,857
Theriva Biologics (TOVX)
Develops stroma-degrading oncolytic viruses for difficult-to-treat solid tumors.
$0.2320
vs last close+0.00 (+0.52%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 4.32% | 1.98M shares | |
|---|---|---|---|
| 24 holders · as of Jun 30, 2026 | |||
| Other | 95.68% | 43.91M shares | |
| remainder | |||
45.89M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
24 holders · 1.98M shares · 6 new positions · 11 increased · 6 reduced · 2 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 486.2K | 1.06% | +293.8K | Aug 13, 2026 |
| Jane Street Group, LLC | 331.9K | 0.72% | +154.9K | Aug 14, 2026 |
| Geode Capital Management, LLC | 294.0K | 0.64% | −156.2K | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 241.8K | 0.53% | 0 | Aug 13, 2026 |
| Ikarian Capital, LLC | 112.1K | 0.24% | 0 | Aug 14, 2026 |
| Virtu Financial LLC | 87.1K | 0.19% | −166.1K | Aug 13, 2026 |
| Northern Trust Corp | 82.7K | 0.18% | +82.7Knew | Aug 13, 2026 |
| Renaissance Technologies LLC | 63.7K | 0.14% | +63.7Knew | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Heights Capital Management, Inc.incl. CVI Investments, Inc. | 9.90% | 13G | Oct 2, 2024 | |
| Jeffrey Matthew Gryga Irrevocable Trust | 7.70% | 739.2K | 13G | Nov 10, 2025 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.